Home › Stock analysis › SGP
SpyGlass Pharma (SGP) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $24.72, +4.35% vs the prior close of $23.69.
- Volume 47.10K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SGP jumps 4.3% to $24.72. Closed at $24.72, +4.35% vs the prior close of $23.69. Day range $23.50–$24.93, opened at $23.67.
Last close$24.72+4.35%
Day range23.50–24.93
Open23.67
Volume47.10K
52-week range17.06–32.44
Avg volume (20d)121.69K
SGP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SGP jumps 4.3% to $24.72
- Closed at $24.72, +4.35% vs the prior close of $23.69. Day range $23.50–$24.93, opened at $23.67.
- Volume was 47.10K shares, 0.5x its 50-day average of 104.38K — lighter than usual.
- Price is -6.8% vs its 50-day average ($26.51).
- 52-week range $17.06–$32.44; today's close sits at 50% of that range, 23.8% below the 52-week high.
Oct 14, 2026 — SGP dips 1.0% to $23.69, a 1-month low, 3 down days in a row
- Closed at $23.69, -0.96% vs the prior close of $23.92. Day range $22.80–$24.21, opened at $23.72.
- Volume was 49.10K shares, 0.5x its 50-day average of 105.27K — lighter than usual.
- Price is -10.6% vs its 50-day average ($26.49).
- 52-week range $17.06–$32.44; today's close sits at 43% of that range, 27.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — SGP slides 3.8% to $23.92
- Closed at $23.92, -3.78% vs the prior close of $24.86. Day range $23.89–$24.85, opened at $24.53.
- Volume was 63.90K shares, 0.6x its 50-day average of 106.06K.
- Price is -9.7% vs its 50-day average ($26.50).
- 52-week range $17.06–$32.44; today's close sits at 45% of that range, 26.3% below the 52-week high.
Oct 12, 2026 — SGP ends flat (-0.2%) to $24.86
- Closed at $24.86, -0.24% vs the prior close of $24.92. Day range $24.14–$25.54, opened at $24.60.
- Volume was 59.50K shares, 0.6x its 50-day average of 106.10K — lighter than usual.
- Price is -6.1% vs its 50-day average ($26.47).
- 52-week range $17.06–$32.44; today's close sits at 51% of that range, 23.4% below the 52-week high.
Oct 9, 2026 — SGP rises 1.2% to $24.92
- Closed at $24.92, +1.22% vs the prior close of $24.62. Day range $24.63–$25.79, opened at $25.03.
- Volume was 68.30K shares, 0.6x its 50-day average of 106.65K.
- Price is -5.7% vs its 50-day average ($26.43).
- 52-week range $17.06–$32.44; today's close sits at 51% of that range, 23.2% below the 52-week high.
Oct 8, 2026 — SGP jumps 3.0% to $24.62
- Closed at $24.62, +3.01% vs the prior close of $23.90. Day range $23.29–$24.84, opened at $23.56.
- Volume was 64.60K shares, 0.6x its 50-day average of 107.70K — lighter than usual.
- Price is -6.7% vs its 50-day average ($26.38).
- 52-week range $17.06–$32.44; today's close sits at 49% of that range, 24.1% below the 52-week high.
Oct 7, 2026 — SGP slides 3.6% to $23.90, a 1-month low
- Closed at $23.90, -3.55% vs the prior close of $24.78. Day range $23.62–$24.76, opened at $24.46.
- Volume was 69.50K shares, 0.6x its 50-day average of 107.71K.
- Price is -9.2% vs its 50-day average ($26.33).
- 52-week range $17.06–$32.44; today's close sits at 44% of that range, 26.3% below the 52-week high.
Oct 6, 2026 — SGP slides 3.2% to $24.78, a 1-month low
- Closed at $24.78, -3.17% vs the prior close of $25.59. Day range $24.75–$25.87, opened at $25.76.
- Volume was 81.20K shares, 0.8x its 50-day average of 107.20K.
- Price is -5.7% vs its 50-day average ($26.28).
- 52-week range $17.06–$32.44; today's close sits at 50% of that range, 23.6% below the 52-week high.
Oct 5, 2026 — SGP rises 2.7% to $25.59
- Closed at $25.59, +2.69% vs the prior close of $24.92. Day range $24.60–$25.71, opened at $24.78.
- Volume was 133.10K shares, 1.2x its 50-day average of 106.62K.
- Price is -2.3% vs its 50-day average ($26.20).
- 52-week range $17.06–$32.44; today's close sits at 55% of that range, 21.1% below the 52-week high.
Oct 2, 2026 — SGP slides 6.0% to $24.92, a 1-month low
- Closed at $24.92, -5.96% vs the prior close of $26.50. Day range $24.68–$27.11, opened at $26.73.
- Volume was 142.10K shares, 1.3x its 50-day average of 105.28K.
- Price is -4.5% vs its 50-day average ($26.10).
- 52-week range $17.06–$32.44; today's close sits at 51% of that range, 23.2% below the 52-week high.
SGP latest news & SEC filings
Every SEC filing by or about SGP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$19.86M (prior year -$8.68M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.59 (prior year -$3.81) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade SGP
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.61% (largest 6.0%).
- Liquidity: about 121.69K shares (≈$3.01M) trade per day on average.
- 52-week position: $24.72 vs a range of $17.06–$32.44 (50% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Geoffrey B Pardo bought 312,500 shares on Feb 9, 2026.
- Latest filings: 8-K Oct 1, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
SGP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 23.67 | 24.93 | 23.50 | 24.72 | 47.10K |
| Oct 14, 2026 | 23.72 | 24.21 | 22.80 | 23.69 | 49.10K |
| Oct 13, 2026 | 24.53 | 24.85 | 23.89 | 23.92 | 63.90K |
| Oct 12, 2026 | 24.60 | 25.54 | 24.14 | 24.86 | 59.50K |
| Oct 9, 2026 | 25.03 | 25.79 | 24.63 | 24.92 | 68.30K |
| Oct 8, 2026 | 23.56 | 24.84 | 23.29 | 24.62 | 64.60K |
| Oct 7, 2026 | 24.46 | 24.76 | 23.62 | 23.90 | 69.50K |
| Oct 6, 2026 | 25.76 | 25.87 | 24.75 | 24.78 | 81.20K |
| Oct 5, 2026 | 24.78 | 25.71 | 24.60 | 25.59 | 133.10K |
| Oct 2, 2026 | 26.73 | 27.11 | 24.68 | 24.92 | 142.10K |
| Oct 1, 2026 | 26.30 | 26.81 | 25.34 | 26.50 | 101.10K |
| Sep 30, 2026 | 25.44 | 26.52 | 25.05 | 26.00 | 79.60K |
| Sep 29, 2026 | 25.84 | 26.25 | 24.40 | 25.44 | 67.90K |
| Sep 28, 2026 | 26.97 | 27.26 | 25.98 | 25.98 | 120.00K |
| Sep 25, 2026 | 27.51 | 27.92 | 26.85 | 27.07 | 96.40K |
| Sep 24, 2026 | 28.22 | 28.22 | 26.64 | 27.65 | 81.40K |
| Sep 23, 2026 | 28.99 | 29.28 | 27.76 | 28.16 | 149.30K |
| Sep 22, 2026 | 27.98 | 29.07 | 27.85 | 28.69 | 171.70K |
| Sep 21, 2026 | 29.40 | 29.96 | 27.29 | 27.96 | 174.30K |
| Sep 18, 2026 | 29.25 | 29.47 | 27.33 | 29.08 | 613.80K |
About SpyGlass Pharma
SpyGlass Pharma (SGP) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1778922.
SGP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ali Behbahani | Director | Feb 11, 2026 |
| Habib J Dable | Director | Feb 9, 2026 |
| Michael Dybbs | Director | Feb 9, 2026 |
| Malik Y. Kahook | See remarks | Feb 9, 2026 |
| Bilal Arshad Khan | Director | Feb 11, 2026 |
| Peter Kolchinsky | Director | Feb 11, 2026 |
| Patrick H. Mooney | Chief Executive Officer | Feb 9, 2026 |
| Kirk G. Nielsen | Director | Feb 11, 2026 |
| Elizabeth G. O'Farrell | Director | Feb 9, 2026 |
| Geoffrey B Pardo | Director | Feb 11, 2026 |
| Capital Management, L.P. Ra | Director | Feb 11, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Feb 11, 2026 |
| Capital Nexus Fund Iii, L.P. Ra | Director | Feb 11, 2026 |
| Zachary Scheiner | Director | Feb 9, 2026 |
| Rajeev M. Shah | Director | Feb 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James Robert Jr. Dennewill | Chief Operating Officer | Feb 9, 2026 |
| Malik Y. Kahook | See remarks | Feb 9, 2026 |
| Patrick H. Mooney | Chief Executive Officer | Feb 9, 2026 |
| Chetan Pratap Pujara | Chief R&D Officer | Feb 9, 2026 |
| Jean-Frederic Viret | Chief Financial Officer | Feb 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 9, 2026 | Geoffrey B Pardo | Buy | 312,500 | $16.00 |
| Feb 9, 2026 | Scott D Sandell | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Anthony A. Jr. Florence | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Edward T Mathers | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Carmen Chang | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Ali Behbahani | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Bilal Arshad Khan | Buy | 20,000 | $16.00 |
| Feb 9, 2026 | Bilal Arshad Khan | Buy | 115,000 | $16.00 |
| Feb 9, 2026 | 17 Gp, Llc Nea | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Enterprise Associates 17, L.P. New | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Partners 17, L.P. Nea | Buy | 937,500 | $16.00 |
| Feb 9, 2026 | Capital Healthcare Fund Lp Ra | Buy | 248,034 | $16.00 |
| Feb 9, 2026 | Capital Healthcare Fund Lp Ra | Buy | 3,441,966 | $16.00 |
| Feb 9, 2026 | Peter Kolchinsky | Buy | 248,034 | $16.00 |
| Feb 9, 2026 | Peter Kolchinsky | Buy | 3,441,966 | $16.00 |
SGP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-39.87M | -17.98 | $-32.70M |
| Dec 31, 2024 | — | $-29.16M | -16.31 | $-22.03M |
Latest balance sheet: total assets $243.43M, total liabilities $11.07M, cash $223.14M (as of Jun 30, 2026).
SGP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $24.75 |
| May 14, 2026 | 8-K Item 2.02 (results) | $24.27 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $25.20 |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on SGP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.